Impact of surgical field disinfection on vaginal microbiome in transvaginal urogynecological surgery: a prospective cohort study
- PMID: 40859385
- PMCID: PMC12382086
- DOI: 10.1186/s13756-025-01622-6
Impact of surgical field disinfection on vaginal microbiome in transvaginal urogynecological surgery: a prospective cohort study
Abstract
Background: The study aimed to assess the effects of vaginal disinfection and sterile draping on the composition and dynamics of the vaginal microbiota during vaginal surgery.
Methods: A prospective cohort study was conducted involving post-menopausal patients undergoing vaginal urogynecological surgery. The vaginal microbiota was assessed by partial 16 S rRNA gene sequencing at three time points: before disinfection (V1); immediately after disinfection and sterile draping (V2); and one-hour post-disinfection (V3).
Findings: In a cohort of 54 postmenopausal women (median age: 69.2 ± 7.6 years), with a mean operative time of 92.89 ± 45.92 min, native tissue prolapse repair was the most common urogynecological vaginal procedure performed (n = 47, 87%). The vaginal microbiota diversity was significantly increased after disinfection associated with reduced abundance of Lactobacillus and Bifidobacterium and increased Pseudomonas (p < 0.0001). Community state type (CST) I prevalence decreased notably from 20% at V1 to 6% at V3, primarily due to the disappearance of CST I-A, while CST IV prevalence rose from 31 to 44%, which was mainly secondary to an increase in CST IV-C (from 20 to 33%).
Conclusions: These findings highlight the impact of povidone-iodine on vaginal microbiota composition during vaginal urogynecological surgery. Disinfection significantly increased vaginal bacterial diversity and reducing Lactobacillus abundance. This observation requires further exploration in the context of development of optimized disinfection protocols aimed at preserving vaginal health during and after surgery.
Keywords: Lactobacillus; Pseudomonas; CSTs; Disinfection; Povidone-iodine; Urogynecology; Vaginal microbiota diversity; Vaginal surgery.
© 2025. The Author(s).
Conflict of interest statement
Declarations. Ethics approval and consent to participate: This study was approved by an ethics committee n° 2019-A02772-55 and was registered at www.clinicaltrials.gov : NCT 04301401. Competing interests: The authors declare no competing interests.
Figures
References
-
- Nygaard I, Barber MD, Burgio KL, Kenton K, Meikle S, Schaffer J et al. Prevalence of symptomatic pelvic floor disorders in US women. JAMA. 2008;300(11):1311–6. Available from: https://pubmed.ncbi.nlm.nih.gov/18799443/ - PMC - PubMed
-
- Sheth SS. The scope of vaginal hysterectomy. European Journal of Obstetrics and Gynecology and Reproductive Biolog. 200;115(2):224–30. Available from: https://pubmed.ncbi.nlm.nih.gov/15262361/ - PubMed
-
- D’Angelo W, Dziki J, Badylak SF. The challenge of stress incontinence and pelvic organ prolapse: revisiting biologic mesh materials. Curr Opin Urol. 2019;29(4):437–42. Available from: https://pubmed.ncbi.nlm.nih.gov/31083010/ - PubMed
-
- SW MZ. L, T S. Postoperative Wound Infections. Clinical Infectious Disease, Second Edition. 202;729–33. Available from: https://pubmed.ncbi.nlm.nih.gov/32809368/
-
- Black JD, De Haydu C, Fan L, Sheth SS. Surgical site infections in gynecology. Obstet Gynecol Sur. 2014;69(8):501–10. Available from: https://pubmed.ncbi.nlm.nih.gov/25144613/ - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
